Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.98 USD | -2.68% | -0.99% | +75.66% |
Jun. 05 | Y-mAbs Therapeutics, Inc. Appoints Norman LaFrance as Chief Development Officer | CI |
Jun. 01 | Y-mAbs Therapeutics, Inc. Announces Publication of Preclinical GD2-SADA Data | CI |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Bullish | Bullish |
Resistance | 14.71 | 18.69 | 18.69 |
Spread/Res. | -18.56% | -35.90% | -35.90% |
Spread/Supp. | +3.28% | +15.86% | +27.72% |
Support | 11.60 | 10.34 | 9.380 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- YMAB Stock
- Charts Y-mAbs Therapeutics, Inc.